Sponsored Startup

With dozens of successful projects behind us in numerous business fields, we provide best data science project practices.

Business Overview

Active
Operating Status
Feb 2020
Founded
15
Employees
B2B
Business Model
Software
Offering Type
Description

1E Therapeutics (1Etx) is a breakthrough, clinical stage drug development company creating first-in-class RNA-targeting therapeutics based on our proprietary drug design platform. 1E is the culmination of years of innovation, effort, and tens of millions of $US investment in research and development. 1E's proprietary and groundbreaking rapid drug design process has proven uniquely able to develop innovative drugs that address chronic life threatening indications as well as emerging and evolving pathogens. 1E already has lead compounds that address a wide array of indications in oncology and age-related diseases, immunology, anti-microbial resistance, viral infections, and orphan neurological disorders. 1E’s most advanced lead is already in a Phase 1/2 clinical trial, and the company is positioned to have multiple programs in the clinic within the next 2 years.

Sectors

Analytics

Founders

Name

Title

Classification

Contact

Investors

Investor

Investor Type

Series Preference

Angel
Pre-Seed, Seed, Series A, Series B

Funding Rounds

$120,000,000
Total Funding

1

Funding Rounds
Seed
Last Funding Series

Startup Profile Funding Rounds

Date Announced

Funding Round

Amount Raised

Investors

Seed
$120 M

AI Technology Stack™

1
AI Technologies
AI Technologies

© 2021 StartupHub.ai. All rights reserved.

You cannot copy content of this page

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database